Daily Briefing · 2026-10-01

S. 10-year yield climbing to its highest level in fourteen years, rattling investors and pushing up borrowing costs. Inflation is actually cooling while economic growth remains solid, but yields keep rising anyway, as markets brace for rates staying elevated for longer. Hedge funds are piling into Treasuries in a crowded trade that some analysts now flag as a potential risk to financial stability. All eyes are on the September jobs report, with the labor market still stuck in a low-hire, low-fire pattern that's keeping employment growth muted. Across the Atlantic, fiscal troubles in the eurozone appear to be just getting started, adding another layer of pressure to the region's outlook. On the social front, more than ten million older Americans are now living in poverty, and proposed Social Security cuts could push millions more into hardship. In banking, United Bankshares is drawing a buy rating thanks to record dividends and strong capital ratios. AGNC Investment, meanwhile, faces renewed pressure as the Fed's policy shift threatens further pain for the mortgage REIT. In healthcare, ClearPoint Neuro was downgraded to hold after disappointing clinical trial results disrupted its growth story. Regeneron is expanding its antibody collaboration in immunology, bolstering its long-term pipeline and competitive edge. In retail, American Eagle Outfitters was downgraded as signs of a brand slowdown emerge amid softening consumer demand. And in energy, Brookfield Renewable has pulled back into an attractive buy zone after its recent stock decline.